MINI LONG - TAKEDA PHARMACEUTICAL ADR Stock

Certificat

MINI L TAK AVA

GB00BS9MG823

Market Closed - Bid/Ask			After market 15:23:11
- ^SEK	-.--%		1.86	+∞%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TAKEDA PHARMACEUTICAL COMPANY LIMITED

Chart MINI LONG - TAKEDA PHARMACEUTICAL ADR

Latest news about TAKEDA PHARMACEUTICAL COMPANY LIMITED

Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder	04-23	PR
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs	04-22	PR
Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation	01-25	PR
Takeda Launches CDPATH™, a Personalized Prognostic Tool, Advancing Innovation for Patients with Crohn's Disease	22-09-14	PR

More news

Static data

Product type	Knock-Out mit Stop Loss
Buy / Sell	CALL
Underlying	TAKEDA PHARMACEUTICAL COMPANY LIMITED
Issuer	Morgan Stanley
	MINI L TAK AVA
ISIN	GB00BS9MG823
Date issued	2024-03-28
Strike	11.72 $
Maturity	Unlimited
Parity	10 : 1
Emission price	- kr
Emission volume	N/A
Settlement	Barausgleich
Currency	SEK

Technical Indicators

Spread	0.02 kr
Spread %	1.07%

Company Profile

Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas: - sale of drugs and consumer care products; - services. Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).

Sector

More about the company